BEAR CERTIFICATE - ORION B Stock

Certificat

BEAR ORION X2 N

SE0016278758

Market Closed - Nasdaq Helsinki 05:08:55 2024-04-26 am EDT
4.51 ^EUR	-2.38%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ORION OYJ

Latest news about ORION OYJ

Orion Partners with Universities for Biotechnology Project in Finland	Jun. 03	MT
Orion is developing the Finnish life science industry in a unique collaboration project	Jun. 03	GL
Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025	May. 07	GL
Orion Corporation Announces Change in Orion Group Executive Management Board as of 31 May 2025	May. 07	CI

More news

Static data

Product type	Exotic Products
Buy / Sell	PUT
Underlying	ORION OYJ
Issuer	Nordea
	BEAR ORION X2 N
ISIN	SE0016278758
Date issued	2021-07-08
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	6.53 €
Lowest since issue	3.12 €
Spread	0.02 €
Spread %	0.53%

Company Profile

Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - generic, OTC and biosimilar drugs (43.4%); - patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - animal health products (8.7%); - pharmaceutical ingredients and outsourcing services (6.2%). Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%). Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).

Sector

More about the company